References

Below you will find a short list of publications that have used the antibodies provided through this service:

Cui L, Aleksandrov L, Chang X B, Hou Y X, He L, Hegedus T, Gentzsch M, Aleksandrov A, Balch W E, and Riordan JR (2007). “Domain interdependence in the biosynthetic assembly of CFTR”. Journal of Molecular Biology 365 (4): 981-94
Gentzsch M, Choudhury A, Chang X B, Pagano R E and Riordan (2007).”Misassembled mutant {Delta}F508 CFTR in the distal secretory pathway alters cellular lipid trafficking.” J Cell Sci 120(Pt 3): 447-55
Gentzsch M, Cui L, Mengos A, Chang X B, Chen J H and Riordan J R (2003). “The PDZ-binding chloride channel ClC-3B localizes to the Golgi and associates with cystic fibrosis transmembrane conductance regulator-interacting PDZ proteins.” J Biol Chem 278(8): 6440-9.
Gentzsch M, Chang X B, Cui L, Wu Y, Ozols V V, Choudhury A, Pagano R E and Riordan J R (2004). “Endocytic trafficking routes of wild type and DeltaF508 cystic fibrosis transmembrane conductance regulator.” Mol Biol Cell 15(6): 2684-96.
Grubb B R, Gabriel S E, Mengos A, Gentzsch M, Randell S H, Van Heeckeren A M, Knowles M R, Drumm M L, Riordan J R and Boucher R C (2006). “SERCA pump inhibitors do not correct biosynthetic arrest of deltaF508 CFTR in cystic fibrosis.” Am J Respir Cell Mol Biol 34(3): 355-63.
Hegedus T, Aleksandrov A, Cui L, Gentzsch M, Chang X B and Riordan JR (2006).”F508del CFTR with two altered RXR motifs escapes from ER quality control but its channel activity is thermally sensitive.” Biochim Biophys Acta 1758(5): 565-72.
Kreda S M, Mall M, Mengos A, Rochelle L, Yankaskas J, Riordan J R and Boucher R.C.(2005). “Characterization of wild-type and deltaF508 cystic fibrosis transmembrane regulator in human respiratory epithelia.” Mol Biol Cell 16(5): 2154-67.
Mall M, Kreda S M, Mengos A, Jensen T J, Hirtz S, Seydewitz H H, Yankaskas J, Kunzelmann K, Riordan J R and Boucher R C (2004). “The DeltaF508 mutation results in loss of CFTR function and mature protein in native human colon.” Gastroenterology 126(1): 32-41.
Malmberg E K, Andersson C X, Gentzsch M, Chen J H, Mengos A, Cui L, Hansson G.C. and Riordan J R (2004). “Bcr (breakpoint cluster region) protein binds to PDZ-domains of scaffold protein PDZK1 and vesicle coat protein Mint3.” J Cell Sci 117(Pt 23): 5535-41
He L, Aleksandrov AA, Serohijos AW, Hegedus T, Aleksandrov LA, Cui L, Dokholyan NV, Riordan JR.(2008) “Multiple membrane-cytoplasmic domain contacts in the cystic fibrosis transmembrane conductance regulator (CFTR) mediate regulation of channel gating”. J.Biol Chem. Sept 26 283 (39):26383-90. Epub 2008 Jul 25.
Xiu-bao Chang, April Mengos, Yue-zian Hou, Liying Cui, Timothy J. Jensen, Andrei Aleksandrov, John R. Riordan and Martina Gentzsch (2008) “Role of N-linked oligosaccharides in the biosynthetic processing of the cystic fibrosis membrane conductance regulator.” J Cell Sci 121:2814-2823.
Tamas Hegedus, Andrei Aleksandrov, April Mengos, Liying Cui, Timothy J. Jensen, John R. Riordan. (2009) “Role of individual R domain phosphorylation sites in CFTR regulation by protein kinase A” Biochim Biophys Acta 1788:1341-1349

Cui L, Aleksandrov L, Chang X B, Hou Y X, He L, Hegedus T, Gentzsch M, Aleksandrov A, Balch W E, and Riordan JR (2007). “Domain interdependence in the biosynthetic assembly of CFTR”. Journal of Molecular Biology 365 (4): 981-94

Gentzsch M, Choudhury A, Chang X B, Pagano R E and Riordan (2007).”Misassembled mutant {Delta}F508 CFTR in the distal secretory pathway alters cellular lipid trafficking.” J Cell Sci 120(Pt 3): 447-55

Gentzsch M, Cui L, Mengos A, Chang X B, Chen J H and Riordan J R (2003). “The PDZ-binding chloride channel ClC-3B localizes to the Golgi and associates with cystic fibrosis transmembrane conductance regulator-interacting PDZ proteins.” J Biol Chem 278(8): 6440-9.

Gentzsch M, Chang X B, Cui L, Wu Y, Ozols V V, Choudhury A, Pagano R E and Riordan J R (2004). “Endocytic trafficking routes of wild type and DeltaF508 cystic fibrosis transmembrane conductance regulator.” Mol Biol Cell 15(6): 2684-96.

Grubb B R, Gabriel S E, Mengos A, Gentzsch M, Randell S H, Van Heeckeren A M, Knowles M R, Drumm M L, Riordan J R and Boucher R C (2006). “SERCA pump inhibitors do not correct biosynthetic arrest of deltaF508 CFTR in cystic fibrosis.” Am J Respir Cell Mol Biol 34(3): 355-63.

Hegedus T, Aleksandrov A, Cui L, Gentzsch M, Chang X B and Riordan JR (2006).”F508del CFTR with two altered RXR motifs escapes from ER quality control but its channel activity is thermally sensitive.” Biochim Biophys Acta 1758(5): 565-72.

Kreda S M, Mall M, Mengos A, Rochelle L, Yankaskas J, Riordan J R and Boucher R.C.(2005). “Characterization of wild-type and deltaF508 cystic fibrosis transmembrane regulator in human respiratory epithelia.” Mol Biol Cell 16(5): 2154-67.

Mall M, Kreda S M, Mengos A, Jensen T J, Hirtz S, Seydewitz H H, Yankaskas J, Kunzelmann K, Riordan J R and Boucher R C (2004). “The DeltaF508 mutation results in loss of CFTR function and mature protein in native human colon.” Gastroenterology 126(1): 32-41.

Malmberg E K, Andersson C X, Gentzsch M, Chen J H, Mengos A, Cui L, Hansson G.C. and Riordan J R (2004). “Bcr (breakpoint cluster region) protein binds to PDZ-domains of scaffold protein PDZK1 and vesicle coat protein Mint3.” J Cell Sci 117(Pt 23): 5535-41

Xiu-bao Chang, April Mengos, Yue-zian Hou, Liying Cui, Timothy J. Jensen, Andrei Aleksandrov, John R. Riordan and Martina Gentzsch (2008) “Role of N-linked oligosaccharides in the biosynthetic processing of the cystic fibrosis membrane conductance regulator.” J Cell Sci 121:2814-2823.

Tamas Hegedus, Andrei Aleksandrov, April Mengos, Liying Cui, Timothy J. Jensen, John R. Riordan. (2009) “Role of individual R domain phosphorylation sites in CFTR regulation by protein kinase A” Biochim Biophys Acta 1788:1341-1349